Skip to main content
Erschienen in: Wiener klinische Wochenschrift 17-18/2021

18.06.2021 | original article

Impact of COVID-19 pandemic on outpatient appointments of rheumatic patients in a non-outbreak area of China

verfasst von: Tianhua Xie, MD, Dong Wang, MD, Xia Wang, MD, Qingrui Yang, MD, Hongsheng Sun, MD, Ruihong Liu, MD, Ming Li, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 17-18/2021

Einloggen, um Zugang zu erhalten

Summary

Background

Coronavirus disease 2019 (COVID-19) infection has caused huge impacts on all of people’s lives and health systems. In response to the COVID-19 pandemic, China was the first country to impose lockdown. We aimed to study the influence of COVID-19 on the outpatient visits of rheumatic patients in a non-outbreak area of China.

Methods

We selected three provincial or ministerial hospitals in Jinan, and collected the outpatient appointments data in rheumatology and immunology departments during the Shandong Province first-level public health emergency response period from 25 January 2020 to 8 March 2020.

Results

In the early stage, the number of outpatient appointments in the rheumatology and immunology departments of the three provincial or ministerial hospitals were significantly reduced, and gradually restored in the late stage. It showed that in the face of major infectious diseases, strict quarantine measures with the cooperation of the public not only controls the epidemic in a short time, but also lifts the quarantine measures and opens general outpatient clinics in hospitals as soon as possible, thus minimizing the impact on other patients.

Interpretation

The impact on the western hospital was greater than that on the Chinese medicine hospital, and the impact on the back-up designated hospitals for COVID-19 was the greatest. Online appointment can reduce the risk of infection in outpatients, but not completely solve the follow-up problem of rheumatic patients. Telemedicine provides a new solution for both management of rheumatic patients and control of COVID-19.
Literatur
1.
Zurück zum Zitat Zhu N, Zhang D, Wang W, et al. China novel Coronavirus investigating and research team. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.CrossRef Zhu N, Zhang D, Wang W, et al. China novel Coronavirus investigating and research team. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.CrossRef
27.
Zurück zum Zitat Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Ann Rheum Dis. 2020;79(6):840–2. https://doi.org/10.1136/annrheumdis-2020-217628.CrossRefPubMed Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/COVID-19 pandemic. Ann Rheum Dis. 2020;79(6):840–2. https://​doi.​org/​10.​1136/​annrheumdis-2020-217628.CrossRefPubMed
Metadaten
Titel
Impact of COVID-19 pandemic on outpatient appointments of rheumatic patients in a non-outbreak area of China
verfasst von
Tianhua Xie, MD
Dong Wang, MD
Xia Wang, MD
Qingrui Yang, MD
Hongsheng Sun, MD
Ruihong Liu, MD
Ming Li, MD
Publikationsdatum
18.06.2021
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 17-18/2021
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-021-01891-2

Weitere Artikel der Ausgabe 17-18/2021

Wiener klinische Wochenschrift 17-18/2021 Zur Ausgabe